Coronavirus Test Kits Market in North America 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	147 Pages	TechNavio	October, 2023	INF18215924

Best Price Guarantee
Price	from $2,500
Length	147 Pages
Publisher	TechNavio
Published Date	October, 2023
SKU	INF18215924

Test Kits Market In North America 2023-2027

The test kits market in North America is forecasted to grow by USD -8.77 bn during 2022-2027, decelerating at a CAGR of -23.81% during the forecast period. The report on the test kits market in North America provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising adoption of rapid coronavirus test kits, fastrack approval of coronavirus diagnostic kits, and government initiatives to boost sales of coronavirus test kits.

Technavio's test kits market in North America is segmented as below:

By End-user

Government
Non-government

By Type

Rapid test kit
RT-PCR
Others

This study identifies the launch of new covid-19 test kits as one of the prime reasons driving the test kits market in North America growth during the next few years. Also, emergence of new covid-19 variants and advancements in technology to develop rapid and accurate test kits will lead to sizable demand in the market.

The report on the test kits market in North America covers the following areas:

Test kits market in North America sizing
Test kits market in North America forecast
Test kits market in North America industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading test kits market in North America vendors that include Abbott Laboratories, Advaite Inc., Becton Dickinson and Co., Biomedomics Inc., bioMerieux SA, Cellex Inc., Co Diagnostics Inc., Cue Health Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Laboratory Corp. of America Holdings, Mammoth Biosciences Inc., MyBioSource Inc., QIAGEN NV, Quidelortho Corp., RayBiotech Life Inc., Robert Bosch GmbH, SHERLOCK BIOSCIENCES, Talis Biomedical Corp., and Thermo Fisher Scientific Inc.. Also, the test kits market in North America analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary €“ Chart on Market Overview; Exhibit 02: Executive Summary €“ Data Table on Market Overview; Exhibit 03: Executive Summary €“ Chart on Country Market Characteristics; Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary €“ Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Type; Exhibit 07: Executive Summary €“ Chart on Incremental Growth; Exhibit 08: Executive Summary €“ Data Table on Incremental Growth; Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on North America - Market size and forecast 2022-2027 ($ billion); Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion); Exhibit 16: Chart on North America: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
4 Five Forces Analysis: 4.1 Five forces summary; Exhibit 18: Five forces analysis - Comparison between 2022 and 2027; 4.2 Bargaining power of buyers; Exhibit 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027; 4.3 Bargaining power of suppliers; Exhibit 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027; 4.4 Threat of new entrants; Exhibit 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027; 4.5 Threat of substitutes; Exhibit 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027; 4.6 Threat of rivalry; Exhibit 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027; 4.7 Market condition; Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
5 Market Segmentation by End-user: 5.1 Market segments; Exhibit 25: Chart on End-user - Market share 2022-2027 (%); Exhibit 26: Data Table on End-user - Market share 2022-2027 (%); 5.2 Comparison by End-user; Exhibit 27: Chart on Comparison by End-user; Exhibit 28: Data Table on Comparison by End-user; 5.3 Government - Market size and forecast 2022-2027; Exhibit 29: Chart on Government - Market size and forecast 2022-2027 ($ billion); Exhibit 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion); Exhibit 31: Chart on Government - Year-over-year growth 2022-2027 (%); Exhibit 32: Data Table on Government - Year-over-year growth 2022-2027 (%); 5.4 Non-government - Market size and forecast 2022-2027; Exhibit 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibit 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibit 35: Chart on Non-government - Year-over-year growth 2022-2027 (%); Exhibit 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%); 5.5 Market opportunity by End-user; Exhibit 37: Market opportunity by End-user ($ billion); Exhibit 38: Data Table on Market opportunity by End-user ($ billion)
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 39: Chart on Type - Market share 2022-2027 (%); Exhibit 40: Data Table on Type - Market share 2022-2027 (%); 6.2 Comparison by Type; Exhibit 41: Chart on Comparison by Type; Exhibit 42: Data Table on Comparison by Type; 6.3 Rapid test kit - Market size and forecast 2022-2027; Exhibit 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibit 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibit 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%); Exhibit 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%); 6.4 RT-PCR - Market size and forecast 2022-2027; Exhibit 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibit 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibit 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%); Exhibit 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%); 6.5 Others - Market size and forecast 2022-2027; Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%); 6.6 Market opportunity by Type; Exhibit 55: Market opportunity by Type ($ billion); Exhibit 56: Data Table on Market opportunity by Type ($ billion)
7 Customer Landscape: 7.1 Customer landscape overview; Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape: 8.1 Geographic segmentation; Exhibit 58: Chart on Market share By Geographical Landscape - 2022-2027 (%); Exhibit 59: Data Table on Market share By Geographical Landscape - 2022-2027 (%); 8.2 Geographic comparison; Exhibit 60: Chart on Geographic comparison; Exhibit 61: Data Table on Geographic comparison; 8.3 US - Market size and forecast 2022-2027; Exhibit 62: Chart on US - Market size and forecast 2022-2027 ($ billion); Exhibit 63: Data Table on US - Market size and forecast 2022-2027 ($ billion); Exhibit 64: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 65: Data Table on US - Year-over-year growth 2022-2027 (%); 8.4 Canada - Market size and forecast 2022-2027; Exhibit 66: Chart on Canada - Market size and forecast 2022-2027 ($ billion); Exhibit 67: Data Table on Canada - Market size and forecast 2022-2027 ($ billion); Exhibit 68: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibit 69: Data Table on Canada - Year-over-year growth 2022-2027 (%); 8.5 Mexico - Market size and forecast 2022-2027; Exhibit 70: Chart on Mexico - Market size and forecast 2022-2027 ($ billion); Exhibit 71: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion); Exhibit 72: Chart on Mexico - Year-over-year growth 2022-2027 (%); Exhibit 73: Data Table on Mexico - Year-over-year growth 2022-2027 (%); 8.6 Market opportunity By Geographical Landscape; Exhibit 74: Market opportunity By Geographical Landscape ($ billion); Exhibit 75: Data Table on Market opportunity By Geographical Landscape ($ billion)
9 Drivers, Challenges, and Trends: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Exhibit 76: Impact of drivers and challenges in 2022 and 2027; 9.4 Market trends
10 Vendor Landscape: 10.1 Overview; 10.2 Vendor landscape; Exhibit 77: Overview on Criticality of inputs and Factors of differentiation; 10.3 Landscape disruption; Exhibit 78: Overview on factors of disruption; 10.4 Industry risks; Exhibit 79: Impact of key risks on business
11 Vendor Analysis: 11.1 Vendors covered; Exhibit 80: Vendors covered; 11.2 Market positioning of vendors; Exhibit 81: Matrix on vendor position and classification; 11.3 Abbott Laboratories; Exhibit 82: Abbott Laboratories - Overview; Exhibit 83: Abbott Laboratories - Business segments; Exhibit 84: Abbott Laboratories - Key news; Exhibit 85: Abbott Laboratories - Key offerings; Exhibit 86: Abbott Laboratories - Segment focus; 11.4 Advaite Inc.; Exhibit 87: Advaite Inc. - Overview; Exhibit 88: Advaite Inc. - Product / Service; Exhibit 89: Advaite Inc. - Key offerings; 11.5 Becton Dickinson and Co.; Exhibit 90: Becton Dickinson and Co. - Overview; Exhibit 91: Becton Dickinson and Co. - Business segments; Exhibit 92: Becton Dickinson and Co. - Key news; Exhibit 93: Becton Dickinson and Co. - Key offerings; Exhibit 94: Becton Dickinson and Co. - Segment focus; 11.6 Biomedomics Inc.; Exhibit 95: Biomedomics Inc. - Overview; Exhibit 96: Biomedomics Inc. - Product / Service; Exhibit 97: Biomedomics Inc. - Key offerings; 11.7 bioMerieux SA; Exhibit 98: bioMerieux SA - Overview; Exhibit 99: bioMerieux SA - Product / Service; Exhibit 100: bioMerieux SA - Key news; Exhibit 101: bioMerieux SA - Key offerings; 11.8 Cellex Inc.; Exhibit 102: Cellex Inc. - Overview; Exhibit 103: Cellex Inc. - Product / Service; Exhibit 104: Cellex Inc. - Key offerings; 11.9 Co Diagnostics Inc.; Exhibit 105: Co Diagnostics Inc. - Overview; Exhibit 106: Co Diagnostics Inc. - Product / Service; Exhibit 107: Co Diagnostics Inc. - Key news; Exhibit 108: Co Diagnostics Inc. - Key offerings; 11.10 Cue Health Inc.; Exhibit 109: Cue Health Inc. - Overview; Exhibit 110: Cue Health Inc. - Product / Service; Exhibit 111: Cue Health Inc. - Key offerings; 11.11 Danaher Corp.; Exhibit 112: Danaher Corp. - Overview; Exhibit 113: Danaher Corp. - Business segments; Exhibit 114: Danaher Corp. - Key news; Exhibit 115: Danaher Corp. - Key offerings; Exhibit 116: Danaher Corp. - Segment focus; 11.12 DiaSorin SpA; Exhibit 117: DiaSorin SpA - Overview; Exhibit 118: DiaSorin SpA - Business segments; Exhibit 119: DiaSorin SpA - Key news; Exhibit 120: DiaSorin SpA - Key offerings; Exhibit 121: DiaSorin SpA - Segment focus; 11.13 F. Hoffmann La Roche Ltd.; Exhibit 122: F. Hoffmann La Roche Ltd. - Overview; Exhibit 123: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 124: F. Hoffmann La Roche Ltd. - Key news; Exhibit 125: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 126: F. Hoffmann La Roche Ltd. - Segment focus; 11.14 Hologic Inc.; Exhibit 127: Hologic Inc. - Overview; Exhibit 128: Hologic Inc. - Business segments; Exhibit 129: Hologic Inc. - Key news; Exhibit 130: Hologic Inc. - Key offerings; Exhibit 131: Hologic Inc. - Segment focus; 11.15 Laboratory Corp. of America Holdings; Exhibit 132: Laboratory Corp. of America Holdings - Overview; Exhibit 133: Laboratory Corp. of America Holdings - Business segments; Exhibit 134: Laboratory Corp. of America Holdings - Key news; Exhibit 135: Laboratory Corp. of America Holdings - Key offerings; Exhibit 136: Laboratory Corp. of America Holdings - Segment focus; 11.16 QIAGEN NV; Exhibit 137: QIAGEN NV - Overview; Exhibit 138: QIAGEN NV - Product / Service; Exhibit 139: QIAGEN NV - Key news; Exhibit 140: QIAGEN NV - Key offerings; 11.17 Thermo Fisher Scientific Inc.; Exhibit 141: Thermo Fisher Scientific Inc. - Overview; Exhibit 142: Thermo Fisher Scientific Inc. - Business segments; Exhibit 143: Thermo Fisher Scientific Inc. - Key news; Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Exhibit 146: Inclusions checklist; Exhibit 147: Exclusions checklist; 12.3 Currency conversion rates for US$; Exhibit 148: Currency conversion rates for US$; 12.4 Research methodology; Exhibit 149: Research methodology; Exhibit 150: Validation techniques employed for market sizing; Exhibit 151: Information sources; 12.5 List of abbreviations; Exhibit 152: List of abbreviations; Exhibits:; Exhibits1: Executive Summary €“ Chart on Market Overview; Exhibits2: Executive Summary €“ Data Table on Market Overview; Exhibits3: Executive Summary €“ Chart on Country Market Characteristics; Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibits5: Executive Summary €“ Chart on Market Segmentation by End-user; Exhibits6: Executive Summary €“ Chart on Market Segmentation by Type; Exhibits7: Executive Summary €“ Chart on Incremental Growth; Exhibits8: Executive Summary €“ Data Table on Incremental Growth; Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on North America - Market size and forecast 2022-2027 ($ billion); Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion); Exhibits16: Chart on North America: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion); Exhibits18: Five forces analysis - Comparison between 2022 and 2027; Exhibits19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027; Exhibits20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027; Exhibits21: Threat of new entrants €“ Impact of key factors in 2022 and 2027; Exhibits22: Threat of substitutes €“ Impact of key factors in 2022 and 2027; Exhibits23: Threat of rivalry €“ Impact of key factors in 2022 and 2027; Exhibits24: Chart on Market condition - Five forces 2022 and 2027; Exhibits25: Chart on End-user - Market share 2022-2027 (%); Exhibits26: Data Table on End-user - Market share 2022-2027 (%); Exhibits27: Chart on Comparison by End-user; Exhibits28: Data Table on Comparison by End-user; Exhibits29: Chart on Government - Market size and forecast 2022-2027 ($ billion); Exhibits30: Data Table on Government - Market size and forecast 2022-2027 ($ billion); Exhibits31: Chart on Government - Year-over-year growth 2022-2027 (%); Exhibits32: Data Table on Government - Year-over-year growth 2022-2027 (%); Exhibits33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibits34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibits35: Chart on Non-government - Year-over-year growth 2022-2027 (%); Exhibits36: Data Table on Non-government - Year-over-year growth 2022-2027 (%); Exhibits37: Market opportunity by End-user ($ billion); Exhibits38: Data Table on Market opportunity by End-user ($ billion); Exhibits39: Chart on Type - Market share 2022-2027 (%); Exhibits40: Data Table on Type - Market share 2022-2027 (%); Exhibits41: Chart on Comparison by Type; Exhibits42: Data Table on Comparison by Type; Exhibits43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibits44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibits45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%); Exhibits46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%); Exhibits47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibits48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibits49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%); Exhibits50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%); Exhibits51: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibits52: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibits53: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits54: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits55: Market opportunity by Type ($ billion); Exhibits56: Data Table on Market opportunity by Type ($ billion); Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits58: Chart on Market share By Geographical Landscape - 2022-2027 (%); Exhibits59: Data Table on Market share By Geographical Landscape - 2022-2027 (%); Exhibits60: Chart on Geographic comparison; Exhibits61: Data Table on Geographic comparison; Exhibits62: Chart on US - Market size and forecast 2022-2027 ($ billion); Exhibits63: Data Table on US - Market size and forecast 2022-2027 ($ billion); Exhibits64: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits65: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits66: Chart on Canada - Market size and forecast 2022-2027 ($ billion); Exhibits67: Data Table on Canada - Market size and forecast 2022-2027 ($ billion); Exhibits68: Chart on Canada - Year-over-year growth 2022-2027 (%); Exhibits69: Data Table on Canada - Year-over-year growth 2022-2027 (%); Exhibits70: Chart on Mexico - Market size and forecast 2022-2027 ($ billion); Exhibits71: Data Table on Mexico - Market size and forecast 2022-2027 ($ billion); Exhibits72: Chart on Mexico - Year-over-year growth 2022-2027 (%); Exhibits73: Data Table on Mexico - Year-over-year growth 2022-2027 (%); Exhibits74: Market opportunity By Geographical Landscape ($ billion); Exhibits75: Data Table on Market opportunity By Geographical Landscape ($ billion); Exhibits76: Impact of drivers and challenges in 2022 and 2027; Exhibits77: Overview on Criticality of inputs and Factors of differentiation; Exhibits78: Overview on factors of disruption; Exhibits79: Impact of key risks on business; Exhibits80: Vendors covered; Exhibits81: Matrix on vendor position and classification; Exhibits82: Abbott Laboratories - Overview; Exhibits83: Abbott Laboratories - Business segments; Exhibits84: Abbott Laboratories - Key news; Exhibits85: Abbott Laboratories - Key offerings; Exhibits86: Abbott Laboratories - Segment focus; Exhibits87: Advaite Inc. - Overview; Exhibits88: Advaite Inc. - Product / Service; Exhibits89: Advaite Inc. - Key offerings; Exhibits90: Becton Dickinson and Co. - Overview; Exhibits91: Becton Dickinson and Co. - Business segments; Exhibits92: Becton Dickinson and Co. - Key news; Exhibits93: Becton Dickinson and Co. - Key offerings; Exhibits94: Becton Dickinson and Co. - Segment focus; Exhibits95: Biomedomics Inc. - Overview; Exhibits96: Biomedomics Inc. - Product / Service; Exhibits97: Biomedomics Inc. - Key offerings; Exhibits98: bioMerieux SA - Overview; Exhibits99: bioMerieux SA - Product / Service; Exhibits100: bioMerieux SA - Key news; Exhibits101: bioMerieux SA - Key offerings; Exhibits102: Cellex Inc. - Overview; Exhibits103: Cellex Inc. - Product / Service; Exhibits104: Cellex Inc. - Key offerings; Exhibits105: Co Diagnostics Inc. - Overview; Exhibits106: Co Diagnostics Inc. - Product / Service; Exhibits107: Co Diagnostics Inc. - Key news; Exhibits108: Co Diagnostics Inc. - Key offerings; Exhibits109: Cue Health Inc. - Overview; Exhibits110: Cue Health Inc. - Product / Service; Exhibits111: Cue Health Inc. - Key offerings; Exhibits112: Danaher Corp. - Overview; Exhibits113: Danaher Corp. - Business segments; Exhibits114: Danaher Corp. - Key news; Exhibits115: Danaher Corp. - Key offerings; Exhibits116: Danaher Corp. - Segment focus; Exhibits117: DiaSorin SpA - Overview; Exhibits118: DiaSorin SpA - Business segments; Exhibits119: DiaSorin SpA - Key news; Exhibits120: DiaSorin SpA - Key offerings; Exhibits121: DiaSorin SpA - Segment focus; Exhibits122: F. Hoffmann La Roche Ltd. - Overview; Exhibits123: F. Hoffmann La Roche Ltd. - Business segments; Exhibits124: F. Hoffmann La Roche Ltd. - Key news; Exhibits125: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits126: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits127: Hologic Inc. - Overview; Exhibits128: Hologic Inc. - Business segments; Exhibits129: Hologic Inc. - Key news; Exhibits130: Hologic Inc. - Key offerings; Exhibits131: Hologic Inc. - Segment focus; Exhibits132: Laboratory Corp. of America Holdings - Overview; Exhibits133: Laboratory Corp. of America Holdings - Business segments; Exhibits134: Laboratory Corp. of America Holdings - Key news; Exhibits135: Laboratory Corp. of America Holdings - Key offerings; Exhibits136: Laboratory Corp. of America Holdings - Segment focus; Exhibits137: QIAGEN NV - Overview; Exhibits138: QIAGEN NV - Product / Service; Exhibits139: QIAGEN NV - Key news; Exhibits140: QIAGEN NV - Key offerings; Exhibits141: Thermo Fisher Scientific Inc. - Overview; Exhibits142: Thermo Fisher Scientific Inc. - Business segments; Exhibits143: Thermo Fisher Scientific Inc. - Key news; Exhibits144: Thermo Fisher Scientific Inc. - Key offerings; Exhibits145: Thermo Fisher Scientific Inc. - Segment focus; Exhibits146: Inclusions checklist; Exhibits147: Exclusions checklist; Exhibits148: Currency conversion rates for US$; Exhibits149: Research methodology; Exhibits150: Validation techniques employed for market sizing; Exhibits151: Information sources; Exhibits152: List of abbreviations